“Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study”, Braz. J. Pharm. Sci., vol. 56, p. e18447, Dec. 2020, doi: 10.1590/s2175-97902019000418447.